BioCentury
ARTICLE | Company News

Teva acquires Merck KGaA's women's health unit

October 29, 2010 12:55 AM UTC

Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) plans to acquire Theramex, the women's health unit of Merck KGaA (Xetra:MRK), for EUR 265 million ($371.9 million) in cash, plus potential milestones....